No. J9277 is a HCPCS Level II code, maintained by CMS, that identifies the drug supplied. CPT codes are five-digit numbers from the AMA that describe services. Giving the drug, for example an injection or infusion, is usually reported with a separate CPT administration code.

What NDCs are billed under J9277?

CMS's ASP crosswalk for October 1, 2026 through December 31, 2026 lists 2 NDCs under J9277, for Keytruda Qlex. The table on this page shows each one with its billing units per package.

What is the Medicare payment limit for J9277?

$32.307 per 1 mg, effective October 1, 2026 through December 31, 2026, from CMS's Part B drug payment limit file. Multiply by the units billed for the allowed amount before deductible and coinsurance. It is not a coverage decision.

What is one billing unit of J9277?

One unit of J9277 is 1 mg and berahyaluronidase alfa-pmph, as stated in the code's descriptor. Units to report = dose given ÷ 1 mg and berahyaluronidase alfa-pmph.

J9277 J-Code: Keytruda Qlex (pembrolizumab)

In short

J9277 is the HCPCS Level II code for injection, pembrolizumab, 1 mg and berahyaluronidase alfa-pmph. CMS assigns NDCs for Keytruda Qlex to it. One billing unit is 1 mg and berahyaluronidase alfa-pmph. The Medicare Part B payment limit is $32.307 per unit (October 1, 2026 through December 31, 2026).

Code

CMS HCPCS file

HCPCS codeJ9277

Billing unit1 mg and berahyaluronidase alfa-pmph

Descriptor: Injection, pembrolizumab, 1 mg and berahyaluronidase alfa-pmph
Short descriptor: Pembrolizumab 1mg berahyalur
Code set: HCPCS Level II, maintained by CMS
Effective: Apr 1, 2026

The billing unit is read from the descriptor. Confirm it against the CMS file before billing.

Medicare Part B payment limit

CMS ASP file

Payment limit per unit$32.307

Per1 mg

Coinsurance20%

Effective October 1, 2026 through December 31, 2026. Payment allowance limits subject to the ASP methodology are based on 2Q26 ASP data. A payment limit is not a coverage decision; the Medicare contractor decides coverage. CMS ASP pricing files

Units and claim line

Units = dose given ÷ 1 mg and berahyaluronidase alfa-pmph. For example, 100 mg is 100 units. Enter the dose to get the units and the NDC line for the CMS-1500 and the 837P.

Dose given (mg)

HCPCS units (1 unit = 1 mg)

Modifier

NDC (11-digit)

NDC unit qualifier

NDC quantity

Enter the dose given to build the claim line.

NDCs billed under J9277

CMS’s ASP NDC–HCPCS crosswalk (effective October 1, 2026 through December 31, 2026) assigns 2 NDCs to J9277 for Keytruda Qlex. Billing units per package are CMS’s figures for this code’s unit.

NDCs assigned to J9277 in the CMS ASP crosswalk
Drug	NDC (11-digit)	Labeler	Package	Billing units per package
Keytruda Qlex	00006-3083-01	Merck Sharp & Dohme LLC	2.4	395
Keytruda Qlex	00006-5083-01	Merck Sharp & Dohme LLC	4.8	790

J9277: common questions

Is J9277 a CPT code?: No. J9277 is a HCPCS Level II code, maintained by CMS, that identifies the drug supplied. CPT codes are five-digit numbers from the AMA that describe services. Giving the drug, for example an injection or infusion, is usually reported with a separate CPT administration code. CPT codes for drug administration.
What NDCs are billed under J9277?: CMS's ASP crosswalk for October 1, 2026 through December 31, 2026 lists 2 NDCs under J9277, for Keytruda Qlex. The table on this page shows each one with its billing units per package.
What is the Medicare payment limit for J9277?: $32.307 per 1 mg, effective October 1, 2026 through December 31, 2026, from CMS's Part B drug payment limit file. Multiply by the units billed for the allowed amount before deductible and coinsurance. It is not a coverage decision.
What is one billing unit of J9277?: One unit of J9277 is 1 mg and berahyaluronidase alfa-pmph, as stated in the code's descriptor. Units to report = dose given ÷ 1 mg and berahyaluronidase alfa-pmph. J-code billing units.

J9277 — Injection, pembrolizumab, 1 mg and berahyaluronidase alfa-pmph